I3 Energy Plc (ITE.TO) falls 6.67% for May 19

Equities Staff  |

I3 Energy Plc (TSX: ITE.TO) shares fell -6.67% to end trading Wednesday at $0.14 per share - a net change of $-0.01. Shares traded between $0.15 and $0.14 throughout the day.

536655 shares of I3 Energy Plc exchanged hands.

Visit I3 Energy Plc’s profile for more information.

About The TMX Group

TMX Group operates the Toronto Stock Exchange (TSX) and the TSX Venture Exchange, in addition to other derivatives and commodities exchanges. The TSX and TSX Venture Exchange together form the 10th largest stock exchange in the world with over 3,500 listed companies.

To get more information on I3 Energy Plc and to follow the company’s latest updates, you can visit the company’s profile page here: I3 Energy Plc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by Barchart as of 4:30pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Hertz Orders 100,000 Tesla Model 3 Vehicles; First Step Toward Electrifying Fleet
Restaurant Brands International Misses Revenue Estimates; Cites Staffing Shortage, COVID-19
Sustainable Shoe Maker Allbirds Seeks IPO Valuation North of $2 Billion
Stellantis and Samsung SDI Form Joint Venture for Electric Vehicle Batteries
California Proposes Oil and Gas Drilling Buffer Zone Around Communities
Jobless Claims Fall to 290,000 — 19-Month Low
Paul Tudor Jones Calls Inflation 'Single Biggest Threat' to Financial Markets
FDA Expands Booster Dose Usage Authorization for COVID-19 Vaccines



Market Movers

Sponsored Financial Content